RFA-MD-22-010: John Lewis NIMHD Research Endowment Program (S21 Clinical Trial Not Allowed)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2022.
National Institutes of Health offered grants to colleges and universities. Applications closed on January 17, 2023.
From the official notice on Grants.gov, last changed November 7, 2022. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeS21
- Clinical trialsNot allowed
- Funded byNIMHD
- Median yearly award$2.0 million
- Typical project length8 years
Projects funded under RFA-MD-22-010 were run by National Institute on Minority Health and Health Disparities (NIMHD, 6 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-MD-22-010 in the NIH Guide.
Key dates
| Posted | November 7, 2022 |
|---|---|
| Deadline | January 17, 2023 |
| Archived by Grants.gov | February 22, 2023 |
Who can apply
This opportunity was open to colleges and universities.
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Is this a realistic fit?
- Most of the program's money (78% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The purpose of this program is to build capacity and research infrastructure and to facilitate minority health and health disparities research at eligible institutions, but not to directly support the research projects itself. NIMHD Research Endowment grants are made to create a permanent institutional endowment fund to support institutional resources and research capacity building.
Funded under RFA-MD-22-010 so far
NIH funded 6 projects under RFA-MD-22-010 in fiscal 2023 to 2026, at 6 institutions. The median yearly award was $2.0 million.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| TRANSPORT II | SUNY Downstate Medical Center | 2026 | $2.0 million |
| Florida International University-Health Disparities Initiative (FIU-HDI) | Florida International University | 2026 | $2.0 million |
| Endowment for Cardiometabolic Health Disparities Research | Meharry Medical College | 2026 | $2.0 million |
| Texas Center for Health Disparities (TCHD) | University of North Texas HLTH Sci Ctr | 2026 | $2.0 million |
| PREDICT (Precision Medicine, Education, Data Informatics and Community Translation) Institute | Xavier University of Louisiana | 2026 | $2.0 million |
| Charles R. Drew University of Medicine and Science Research Endowment Program | Charles R. Drew University of Med & Sci | 2026 | $2.0 million |
Who has won Minority Health and Health Disparities Research grants before
From fiscal 2021 to 2025, Minority Health and Health Disparities Research (93.307) awarded $2.0 billion across 1,237 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Johns Hopkins University | Maryland | 37 | $69.3 million |
| The Trustees of Columbia University in the City of New York | New York | 25 | $59.1 million |
| University of Hawaii | Hawaii | 18 | $52.8 million |
| The Regents of the University of California, San Francisco | California | 24 | $49.5 million |
| The Morehouse School of Medicine, Inc. | Georgia | 4 | $44.1 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-MD-22-010 still open?
No. It closed on January 17, 2023.
Who can apply for John Lewis NIMHD Research Endowment Program (S21 Clinical Trial Not Allowed)?
National Institutes of Health accepted applications from colleges and universities. The notice adds further conditions, so read its eligibility section.
What is the deadline for John Lewis NIMHD Research Endowment Program (S21 Clinical Trial Not Allowed)?
Closed January 17, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under RFA-MD-22-010?
NIH RePORTER lists 6 projects funded under RFA-MD-22-010 in fiscal 2023 to 2026, at 6 institutions. The most were at SUNY Downstate Medical Center, Florida International University, Meharry Medical College.
Who has won Minority Health and Health Disparities Research grants before?
The largest recipients over five fiscal years were The Johns Hopkins University, The Trustees of Columbia University in the City of New York, University of Hawaii. The program made 1,237 awards worth $2.0 billion in that time.
Similar open grants
- Limited Competition: John Lewis NIMHD Research Endowment Program (S21 Clinical Trial Not Allowed)
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)